Levobupivacaine

Levobupivacaine, the active ingredient in Levobupivacaine, is a local anesthetic presented as a sterile solution for epidural, infiltration, intrathecal, peripheral nerve block use. It provides surgical anesthesia, postoperative analgesia, labor analgesia and peripheral nerve block procedures.

GNH USA supplies Levobupivacaine as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levobupivacaine is employed to achieve analgesia and anesthesia in a range of surgical and obstetric settings.

- Surgical anesthesia: produces complete loss of sensation for operative procedures. - Post‑operative analgesia: reduces pain after surgery to facilitate recovery. - Labor analgesia: provides effective pain relief during childbirth while preserving maternal consciousness. - Peripheral nerve block procedures: enables targeted nerve blockade for limb surgeries or chronic pain management.

Adverse reactions may occur following administration of levobupivacaine.

Common Side Effects: - Hypotension: drop in blood pressure during regional administration. - Bradycardia: slower than normal heart rate observed after epidural use. - Dizziness or light‑headedness. - Nausea or vomiting. - Metallic taste in the mouth. - Headache.

Serious or Rare Side Effects: - Cardiac arrhythmia: potentially life‑threatening rhythm disturbances. - Seizures: central nervous system excitation at high plasma concentrations. - Respiratory depression: reduced breathing effort, especially with intrathecal dosing. - Prolonged motor block: extended loss of muscle function. - Allergic reaction: rash, urticaria or anaphylaxis. - Methemoglobinemia: rare alteration of hemoglobin oxygen‑carrying capacity.

Careful assessment and monitoring are required when using levobupivacaine.

- Monitor cardiovascular status: observe for hypotension and bradycardia during administration. - Assess neurological function: watch for signs of excessive motor block or sensory loss. - Use incremental dosing: avoid large bolus injections to reduce toxicity risk. - Evaluate patient history: consider pre‑existing cardiac or hepatic disease. - Avoid intravascular injection: aspirate before each dose. - Store at ambient temperature: keep in original container, protect from light and moisture.

Levobupivacaine may interact with other medications, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): increase cardiotoxicity. - Beta‑blockers: may potentiate bradycardia. - Other local anesthetics (e.g., bupivacaine): additive neuro‑cardiac toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole): raise plasma concentrations.

Moderate Interactions (Monitor Closely): - Opioids: may enhance sedation and respiratory depression. - Sedatives or hypnotics: increase central nervous system depression. - Epinephrine as an adjunct: can modify absorption rate and systemic exposure.